My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Microbot Medical Inc (MBOT)
NASDAQ:MBOT
MBOT nasdaq
United States
Microbot Medical

Microbot Medical Stock Analysis & Ratings

Microbot Medical Stock Analysis Overview

Smart Score
2
Underperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Microbot Medical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

MBOT

MBOT Stock Stats

Previous Close$7.17
Open$0
Bid6.9 x 1
Ask7.99 x 24
Today’s Range$0 - $0
52-Week Range$6.31 - $10.69
VolumeN/A
Average Volume66.64K
Market Cap$50.97M
Beta4.45
P/E Ratio-5.1
EPS-1.41
Earnings DateNov 17, 2021

Company Description

Microbot Medical Inc

Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.
Sector
Healthcare
Industry
Medical Devices & Instruments
CEO
Harel Gadot
Employees
9
ISIN
US59503A2042
Address
25 Recreation Park Drive, Hingham, MA, 02043, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

MBOT FAQ

What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $6.31 and its highest was $10.69 in the past 12 months.
    What is Microbot Medical’s market cap?
    Microbot Medical’s market cap is $50.97M.
      What is Microbot Medical’s price target?
      Currently, no data Available
      What do analysts say about Microbot Medical?
      Not enough analysts have published a price target to provide an average price target.
      When is Microbot Medical’s upcoming earnings report date?
      Microbot Medical’s upcoming earnings report date is Nov 17, 2021 which is in 29 days.
        How were Microbot Medical’s earnings last quarter?
        Microbot Medical released its earnings results on Mar 31, 2021. The company reported -$0.371 earnings per share for the quarter, missing the consensus estimate of -$0.34 by -$0.031.
          Is Microbot Medical overvalued?
          According to Wall Street analysts Microbot Medical’s price is currently Overvalued.
            Does Microbot Medical pay dividends?
            Microbot Medical does not currently pay dividends.
            What is Microbot Medical’s EPS estimate?
            Microbot Medical’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Microbot Medical have?
            Microbot Medical has 7,110,000 shares outstanding.
              What happened to Microbot Medical’s price movement after its last earnings report?
              Microbot Medical reported an EPS of -$0.371 in its last earnings report, missing expectations of -$0.34. Following the earnings report the stock price went down -1.065%.
                Which hedge fund is a major shareholder of Microbot Medical?
                Currently, no hedge funds are holding shares in MBOT

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis